Articles

European patients navigate new therapies and market change-ups

The drop breaks up degraded protein complexes which cause lens clouding

Specular microscopy showed "long-term alterations" in corneal cells

Smaller surgeries, in greater numbers, await new glaucoma specialists

Determining the medication’s safety and efficacy for paediatric patients

Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis

The biosimilar is indicated to improve and maintain visual acuity for patients with neovascular age-related macular degeneration

Stabilising keratoconus and improving vision using ELZA-PACE customised CXL

Identifying all genetic culprits may improve diagnostics and prognoses

A postcard from the American Society of Retina Specialists meeting in Stockholm

The ALLY Adaptive Cataract Treatment System will be the first EU ALLY commercial installation

A list of 14 risk factors indicate dementia is not an inevitable consequence of aging

The nonprofit Prevent Blindness recognised the awareness month with a slate of resources

In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months

The EMA issued a designation for the small molecule photoswitch, which targets inherited retinal diseases including retinitis pigmentosa

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

Consultant ophthalmologist Christiana Dinah, BSc, MB BS, MRes, presented research findings on retinal vein occlusion in the United Kingdom

Chase Ludwig, MD, speaks about the effect of vitrectomy on the progression of age-related macular degeneration

The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union

At this year's ASRS meeting, Patrick C. Staropoli, MD, discussed his presentation about autosomal dominant pericentral retinitis pigmentosa

Richard B. Rosen, MD, recipient of the ASRS Founders Award for 2024, discusses his presentation at the meeting

At this year's ASRS meeting, Sally S. Ong, MD, shared results from a 10-year study on socioeconomic barriers and visual outcomes

Ashkan Abbey, MD, discusses 36-month outcomes of real-world patients receiving fluocinolone acetonide 0.18 mg

Nikoloz Labauri, MD, FVRS, speaks about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy at ASRS 2024

Jordana Fein, MD, MS, speaks about intraocular pressure outcomes in patients receiving aflibercept through week 48 of the PHOTON trial

Eleonora Lad, MD, PhD, discusses multiwavelength photobiomodulation significantly reduces risk for vision loss and onset of GA in dry AMD

Alan Franklin, MD, PhD, FASRS, a retina specialist in Mobile, Alabama spoke about his presentation, "Intraoperative Fluorescein Angiography Reduces the Rate of Postoperative Vitreous Hemorrhage."

John Thompson, MD, discusses long-term results of using ICG to peel ILM in the treatment of macular holes

Michael Singer, MD, speaks at the American Society of Retina Specialists meeting